Araris Biotech is a company that develops ADC-based safe and potent drugs for various diseases and ailments. Its linker platform enables the attachment of any payload to ‘off the shelf’ antibodies without the need of prior antibody engineering.
|Employees (est.) (Aug 2019)||4|
Araris Biotech total Funding
Araris Biotech latest funding size
Time since last funding
|3 months ago|
Araris Biotech investors
|Schroder Adveq, VI Partners AG, RedAlpine|
When was Araris Biotech founded?
Araris Biotech was founded in 2019.
Who are Araris Biotech key executives?
Araris Biotech's key executives are Philipp Spycher, Isabella Attinger and Dragan Grabulovski.
How many employees does Araris Biotech have?
Araris Biotech has 4 employees.
Who are Araris Biotech competitors?
Competitors of Araris Biotech include ADC Therapeutics, Mersana Therapeutics and NBE-Therapeutics.
Where is Araris Biotech headquarters?
Araris Biotech headquarters is located at HPL, Otto-Stern-Weg 7, Zürich.
Where are Araris Biotech offices?
Araris Biotech has an office in Zürich.
How many offices does Araris Biotech have?
Araris Biotech has 1 office.
Receive alerts for 300+ data fields across thousands of companies